# Vascular Pharmaceuticals, Inc.: Form D filings

Vascular Pharmaceuticals, Inc., a biotechnology company in Chapel Hill, NC, filed 6 Form D notices with the SEC between 2012 and 2016. The latest, on January 6, 2016, reports $3 million sold of a $3 million offering to 6 investors.

Find out what Vascular Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Vascular%20Pharmaceuticals%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Vascular%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fvascular-pharmaceuticals-inc-1557160)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Vascular%20Pharmaceuticals%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Vascular%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fvascular-pharmaceuticals-inc-1557160)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina): 984 rows, by operating companies, filed since November 1, 2024, $49.20, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/north-carolina
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 510 MEADOWMONT VILLAGE CIRCLE, SUITE 283, Chapel Hill, NC, 27517
- Phone: (919) 966-4735
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1557160

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 6, 2016 | New notice | $3,000,000 | $3,000,000 | $0 | 6 | Dec 23, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557160/000155716016000003/0001557160-16-000003-index.htm) |
| Feb 20, 2015 | Amendment | $25,121,488 | $15,121,488 | $10,000,000 | 6 | Sep 10, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557160/000155716015000002/0001557160-15-000002-index.htm) |
| Jan 21, 2015 | Amendment | $19,121,487 | $13,121,487 | $6,000,000 | 4 | Sep 10, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557160/000155716015000001/0001557160-15-000001-index.htm) |
| Nov 19, 2013 | Amendment | $16,008,333 | $9,008,333 | $7,000,000 | 3 | Sep 10, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557160/000155716013000003/0001557160-13-000003-index.htm) |
| Aug 23, 2013 | New notice | $1,500,000 | $1,000,000 | $500,000 | 3 | Aug 15, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557160/000155716013000001/0001557160-13-000001-index.htm) |
| Sep 24, 2012 | New notice | $16,008,333 | $6,008,329 | $10,000,004 | 3 | Sep 10, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557160/000155716012000001/0001557160-12-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Benjamin Rovinski | Director |  |
| Elizabeth Stoner | Director |  |
| David Clemmons | Director |  |
| Richard Shea | Executive Officer, Director |  |
| Bonnie Layman | Executive Officer |  |
| Richard Kent | Director |  |

## Other biotechnology companies in North Carolina that filed recently

- [Toggle Bio](https://specstream.ai/data/form-d/company/toggle-bio-2158695) $200,000 · Oct 6, 2026
- [Swift Cardiovascular, Inc.](https://specstream.ai/data/form-d/company/swift-cardiovascular-inc-2117135) $810,000 · Sep 24, 2026
- [Aclarity Genomics, Inc.](https://specstream.ai/data/form-d/company/aclarity-genomics-inc-2153126) $4.6 million · Sep 2, 2026
- [Aer Therapeutics, Inc.](https://specstream.ai/data/form-d/company/aer-therapeutics-inc-1959576) $3 million · Aug 19, 2026

[Every Form D from the week of Jan 4, 2016](https://specstream.ai/data/form-d/week/2016-01-04) · [All recent filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Vascular Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).